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Host defense mechanisms often appear to  be  inadequate  following  crypto- 
coccal invasion (1-4). Significant antibody response has not been demonstrated 
with  any regularity in  man or experimental animals during  torula  infection. 
Furthermore,  cellular  response  in  cryptococcosis  is  frequently  sparse.  The 
apparent  inadequacy  of  host  antibody  and  cellular  defenses  during  torula 
infection has been related to the presence of a  large capsule, surrounding  the 
cryptococcus  cell,  which  consists  primarily  of  several  polysaccharides  (5). 
Benham  (6)  was able to produce antibodies to cryptococci in  rabbits only after 
the capsule  had been removed with hydrochloric acid. Evans and Kessel (7, 8)  and 
Neill,  CastiUo,  Smith,  and  Kapros  (9),  however,  demonstrated  precipitating and 
agglutinating  antibodies  in  the  rabbit following  immunization  with large numbers 
of heat- or formalin-killed  cryptococci.  These antibodies were  dearly  shown  to  be 
directed against  the  capsular  material.  The  rabbit  does  not  ordinarily  develop 
progressive cryptococcosis  so that no inference  could  be drawn as  to  the protective 
effect of such immunization in this animal. 
In  recent  studies,  Gadebusch  (10) reported  that  he  could  delay  death  in  mice 
following cryptococcal challenge by the administration of immune rabbit serum. These 
as yet unconfirmed  studies suggested  that immune rabbit serum not only contained 
antibody directed against the cryptococcal capsule,  but also was able to modify the 
course  of  a  lethal  cryptococeal infection.  However, the  challenge  organisms  were 
suspended  in mucin, and the antisera and challenge were both given intraperitoneaUy 
within 2 hours of each other. It is quite possible that the apparent protection was 
related to dumping of fungi by the agglutinating antisera, thus in actuality reducing 
the size of the inoculum.  Furthermore, mucin itself can at first reduce and later in- 
crease resistance non-specifically  to many infections  (11). Thus temporary dumping 
of fungus cells by antisera might retard the acute infection long enough to allow non- 
specific resistance to develop. 
Gadebusch (12) also reported that death was delayed in mice infected  with a lethal 
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inoculum of cryptococci by prior injection of purified capsular polysaccharide com- 
bined with a  resin. The specificity of such protection was not investigated. No sig- 
nificant protection was observed when purified capsular polysaccharide was used alone 
as the immunizing agent. 
It  is  thus  unclear  as  to  whether  previous  experience  with  cryptococci or 
cryptococcal  products  can  modify  the  course  of  subsequent  cryptococcus 
infections. In the present studies, mice were inoculated with small numbers of 
highly virulent or large numbers of less virulent living cryptococci. Death was 
delayed and  survival rate was  increased following subsequent  challenge with 
ordinarily lethal inocula. The immunity thus induced appeared to be specific 
and  did  not  confer  protection  against  heterologous  challenge.  Non-specific 
immunity of similar degree could be produced by injection of bacterial endo- 
toxin  1  week prior to  challenge. 
Experiments were also performed in which the course of infection produced 
by small numbers of cryptococci was studied in detail in normal non-immunized 
mice.  Fungus  tissue census  rose markedly during  the  1st week in  all organs 
examined.  Thereafter,  tissue  populations  fell  progressively  with  eventual 
eradication of fungi in most animals. This suggests that host defenses are in 
reality quite effective in mice if infection is initiated with  non-overwhelming 
numbers of cryptococci. 
Materials and Methods 
Mice.-- 
Male Swiss albino mice from Carworth Farms (strain CFW) were used in all experiments. 
Mice weighed  16  to  19  gln.  at  the  start  of  immunization and  23  to  27  gin.  at  the 
time of challenge. Animals were housed in metal cages and were given mouse pellets and water 
ad Ubitum. 
Crypto¢occ~ Stral,s.-- 
Three strains of Cryptococc~ neofo,mans were utilized in these studies: 
(a) Strain 1148, a large capsule strain, was isolated from the cerebrospinal fluid of a patient 
with chronic torulosis in 1954. The total cell size in mouse tissues varied from 12 to 20 ~ ap- 
proximately ~  of which was capsule. A consistent virulence for mice was demonstrated when 
the strain was maintained by twice weekly passage on Sabouraud's agar at 30°C. Eighty to 
100 per cent of mice died within a month following intravenous injection of 2.5 X  106 cells 
or  intracerebral  inoculation  of  5  X  104  cells,  most  of  the  animals  exhibiting  gross 
hydrocephalus. Less frequent subculturing on agar was associated with a decrease in virulence. 
In later experiments,  therefore,  when virulence had diminished  this strain was used for im- 
munization, and will be referred to as avirulent strain 1148. In such studies mice were chal- 
lenged with virulent strain 1149, which was obtained by mouse passage of strain 1148. 
(b) Strain B-27, a small capsule strain, was isolated from a pulmonary toruloma in 1955.  I 
The total cell size both in ~tro and in dvo was 4 to 9 ~, the capsule comprising less than half 
the size of the entire cell. The strain grew moderately well at 37°C. It produced deaths in 
1 This strain was sent to Dr. C. W. Emmons at the National Institutes of Health by Dr. 
L. A. Weed. The author obtained the microorganism in turn from Dr. Emmons. DONALD B.  LOU-RL~  645 
mice uncommonly following inoculation of 5  X  107 cens intraperitoneally, or 5  X  1@ cells 
intracerebrally. When 2.5  X  106 cells were injected intravenously, the mortality rate was 
variable, 10 to 60 per cent dying within 3 months with hydrocephalus. 
(c) Strain J-N, a small capsule strain, was recovered from the cerebrospinal fluid of a patient 
with chronic torula meningitis in 1956.  It was avirulent for mice and did not multiply sig- 
nificantly at 37°C. It could, therefore, be classified as Cryptococcus neoformans var. innocuous. 
Immunization Schedules.- 
Strains B-27 and JN were harvested in saline from Sabouraud's glucose agar slants after 
incubation at 30°C. for 48 (strain B-27) or 72 (strain .IN) hours. The size of the inoculum was 
determined by direct hemocytometer counts in a  Neubauer-Levy chamber. Twenty million 
cells were inoculated intraperitoneally in 0.5 ml. Three such injections were made at 10 day 
intervals, the last injection being 2 weeks prior to challenge. 
Strains 1148 and 1149 were harvested in saline from Sabouraud's agar slants after 24 hours 
incubation at 30°C. Twenty-five thousand cells were inoculated intraperitoneally on a single 
occasion 14 days prior to challenge. 
When strain 1148 had diminished in virulence and was used for immunization, 2.5 X  10  ° 
cells harvested from a  24 hour Sabouraud's agar slant were inoculated intravenously on a 
single occasion 2 to 8 weeks prior to challenge. Mice all appeared well at the time of challenge. 
Virulent strain 1148  was also killed by heating at 60°C.  for 30 minutes. Twenty million 
cells were inoculated intraperitoneally employing the same injection schedule described above 
for strains B-27 and JN. 
Control mice in each experiment were given 0.5 ml. of physiologic saline intraperitoneally 
at 10 day intervals, the last injection being made 2 weeks prior to challenge. 
Non-specific immunity was obtained by a  single intraperitoneal injection of  100 to  200 
~g. of purified Salmonella endotoxin in 0.2 ml. of saline administered 7 days prior to challenge) 
The endotoxin was either freshly dissolved in saline the day of injection, or was stored in 
distilled water at 4°C.  in a  concentration of 10 nag. per ml. and was diluted to the desired 
concentration in 0.85 per cent saline. Lots kept at 4°C. as long as 8 months did not appear 
to lose their immunizing capacity. In 5 of the 6 experiments in which endotoxin was adminis- 
tered, the mice became sick within 24 hours of inoculation. From 0 to 40 per cent of mice in 
each group died during the first 7 days following endotoxin injection. Survivors appeared well 
at the time of challenge with virulent cryptococci. In the sixth study, all mice remained well 
between endotoxin administration and subsequent challenge. 
Challenge Schedules.- 
In each study, groups of immunized or control mice totaled 9 to 15 animals. Cryptococcus 
challenge consisted of 2.5  X  l0  s cells of virulent strains 1148 or 1149.  Ceils were harvested 
in saline from Sabouraud's agar slants incubated at 30°C.  for 24 hours. The inoculum size 
was  determined by direct hemoeytometer count.  One-half ml.  was  injected intravenously 
through a lateral tail vein. 
Mice immunized with eryptoeocci were also challenged with one of three bacteria to de- 
termine the specificity of the immunity. 
(a)  Staphylococcus aureus,  strain AZ. This strain of hemolytic Staphylococcus aureus was 
recovered from  the lungs of  a  patient dying with staphylococcal pneumonia complicating 
Asian influenza in 1957 (13). It was coagulase-positive, fermented mannitol and was lysed by 
bacteriophages 53 VA4, 
The culture was centifuged at 4,500 R.P.M. for 30 minutes after 24 hours growth in beef 
Lots AE 1298 $4 and AE 1688 $4 of pyrexal  ® were kindly supplied by Dr. Russell Schaedler 
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heart infusion broth at 37°C.  The sediment was resuspended in physiologic saline in ~  the 
original volume. One-fifth ml. was inoculated intravenously v/a a  lateral  tail  vein.  This in- 
oculum  , which was approximately 10  s staphylococci per mouse, was highly virulent for normal 
mice, killing 80 to I00 per cent of animals within 14 days (14), 
(b) Klebsidla pneumonia., strain Melton. This strain of Friedl~inder's bacillus which was 
isolated from a human infection was obtained from Dr. Peter Dineen of The New York Hos- 
pital. The strain has remained highly virulent for mice during serial agar passage. All control 
mice died within 7 days after the intravenous injection of 0.2 ml. of a  10  ~  dilution of a  24 
hour infusion broth culture incubated at 37°C. 
(c)  Mycobacterium  tuberculosis,  strain H37Rv.  The history of  this standard  laboratory 
strain of mouse-virulent, human type tubercle bacillus has been thoroughly reviewed  (15). 
When 0.2 ml. of a culture, grown 10 days at 37°C. in tween 80-albumin media, was injected 
intravenously, all control mice died within 2 months. 
Period of Observation.- 
Groups of mice challenged with cryptococci were observed for 3 to 6 months. The experi- 
ment was then terminated. In some experiments 4 or 5 survivors from each group were sacrl- 
riced for determination of  tissue fungus populations.  Mice challenged with Mycobacterium 
tuberculosis, Klebsidla pneumonia., and Staphylococcus aureus were observed until all control 
and immunized mice were dead. 
Determination  of Tissue Populations.-- 
Control and immunized mice were sacrificed for determination of cryptococcus census in 
various tissues at several intervals during the first 14 days of challenge with 2  X  10  e cells. 
Tissue populations were also determined in immunized mice surviving for 3  months after 
challenge with this inoculum. 
Animals were killed by etherization. Liver, lungs, brain, or both kidneys were removed 
aseptically and were emulsified in 2  nil. of distilled water with a  teflon tissue homogenizer 
(16). In some studies liver and spleen were emulsified together. 
Sabouraud's agar pour plates were made of serial 100-fold  dilutions of the tissue homog- 
enate. Plates were incubated at 30°C. and colony counts were determined at 2, 4, and 7 days. 
No attempt was made to separate strains 1148, or 1149,  from strain B-27 in experiments in 
which the latter was used for immunization since it was found that the tissue populations of 
strain B-27 were small at the particular time each organ was studied and did not contribute 
significantly to the total fungus count. Futhermore, strain B-27 grew slowly in agar so that 
colony counts made at 2 to 5 days consisted exclusively of the more rapidly growing virulent 
strains 1148, or 1149. 
Studies with Small Inoeula.-- 
Twenty-seven normal mice were infected intravenously with 10  s cells of strain 1149.  The 
inoculum was harvested in saline from a  Sabouraud's agar slant incubated at 30°C.  for 24 
hours. The number of calls in the suspension was determined by direct hemocytometer count 
and appropriate dilutions were made in saline. One-half ml. of a  suspension containing 2  X 
108 cells was inoculated into each mouse through a  laterai tail vein. The exact size of this 
inoculum was determined by making pour plates of serial 10-fold  dilutions of the injected 
suspension. Pour plates were incubated at 30°C. and colony counts were made at 2, 4, and 7 
days. 
Lung, kidney, brain, and combined llver-spleen populations were determined in groups of 
mice 1 day, 1 week, 1 month, 3 months, and 6 months after infection by techniques described 
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Statistical Analysis.- 
The effect of immunization  was studied by analyzing the cumulative mortality curves and 
by analysis of 3 month survivorship in control and immunized groups. The time of deaths 
following  challenge  was plotted on logarithmetic  probabifity paper. The median time of death 
(ETS0) and significance  of protection were calculated according to the method of Litchfield 
and Wilcoxon (17, 18). Standard "+" tests were also performed.  The significance  of survivor- 
ship in immunized animals as compared to controls was studied by the method of chi square. 
The 3 month interval was chosen because mice that survived 90 days rarely died thereafter 
from cryptococcosis. 
EXPEI~ rM'EA~fAL 
1.  Immunization  witk  Intact  Cryptococcus Cells.-- 
Modification of lethal cryptococcosis was readily demonstrated when mice 
were immunized with intraperitoneal or intravenous injections of intact ceils 
of Cryptococcus neoformans  and were subsequently challenged with 2.5  X  10  n 
ceils of a  virulent strain. A  single intraperitoneal injection of 2.5  X  10  ~ cells 
of strain 1149, or virulent or avirulent strain 1148, a single intravenous inocula- 
tion of 2.5  ×  10  e cells of avirulent strain  1148,  or three intraperitoneal in- 
jections of 2  X  107 cells of small  capsule strain  B-27, all appeared  equally 
effective in  protecting against  challenge with virulent strains  1148  or  1149. 
The results of 2 of the 8 studies are shown in Fig. 1 and 2. In both of these 
experiments the degree of prolongation of life produced by immunization with 
homologous strains  1148  or 1149  or heterologous strain  B-27  was  significant 
at the 1 per cent level. 
Each of the 8 experiments performed is summarized in Table I. It may be 
seen that  the severity of infection and degree of modification by immuniza- 
tion varied considerably. The time of survival of 50 per cent of control mice 
ranged from 16 to 37 days in 6 experiments. In one study it was only 6 days 
and in one, when strain 1148 had diminished in virulence, 50 per cent of controls 
lived for 52 days. 
When  the homologous strain  was  used  for immunization,  prolongation of 
life was significant at the 0.01 level in 4 of 5 studies and at the 0.0S level in the 
fifth  experiment.  When  heterologous strain  B-27  was  used  protection  was 
significant at the 0.01 level in 3 experiments, at the 0.05 level in 5 studies. 
Three month survival was also increased in the immunized animals.  Nine 
of 93 control mice (9.7 per cent) survived the 3  month experimental period. 
Fifty-two of 138  (37.7 per cent) of mice immunized with strains  1148,  1149, 
or B-27 survived a similar period. The difference in survivorship is significant 
at the 1 per cent level. 
There was no evidence in these studies that  immunity was strain-specific. 
Thus immunization with large capsule strains 1148 and 1149 or small capsule 
strain B-27 produced similar protection to challenge with strains 1148 or 1149. 
Immunization  with  Cryptococcus  neoformans  var.  innocuous,  strain  J'N', 
produced less protection. In each of the three experiments in which this strain I00 
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FIG  1.  Effect  of  immunization on mortality in mice following intravenous challenge  with  2.5  X  10  e cells of 
Cryptococcus neoformans, strain 1148.  Immunization schedules consisted of 3  intraperitoneal injections of 2  X  l0  T 
cells of heat-killed strain 1148, small capsule strain B-27, or avirulent strain JN. Ten to 13 mice were in each group. 
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FzG. 2.  Effect of specific and non-specific (endotoxin)  immunization on  mortality in  mice  challenged  intrave- 
nously with 2.5 X  10  ~ cells of Cryptococcus n,oformans, strain  1149.  Each  group  consisted  of 9  to  12  mice.  The 
endotoxin was administered 7 days prior to challenge. 
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was used the severity of the infection was modified, but in only one of these 
studies was the degree of prolongation of life statistically significant (p <  0.05). 
There was no increase in 3 month survival. One of the 3 individual experiments 
is included in Fig. 1 and all 3 are summarized in Table I. 
Immunization with 3 intraperitoneal injections of heat-killed virulent strain 
1148 produced no alteration in the course of lethal cryptococcosis (see Fig.  1 
and Table I). 
2.  Immunization with Bacterial Endotoxin.-- 
Delay in death and increased 3  month survival was demonstrated in 5  of 
the 6 experiments in which 100 to 200 t*g. of Salmonella endotoxin was injected 
intraperitoneally 7 days prior to intravenous challenge with 2.5  X  10  e cells of 
Cryptococcus neoformans strains  1148  or 1149.  The degree of prolongation of 
life was significant at the 0.01 level in 2 of the 5 studies and at the 0.05 level in 
the other 3. 
Thirty of 60 (50 per cent) of endotoxin-treated mice survived the 3 month 
observation period as compared with 9 of the 61  controls (14.8 per cent) in 
these 5  studies.  These differences in survivorship are statistically significant 
at the 0.01 level. 
One of these 5  experiments is depicted in Fig.  2 and all 5  studies  are in- 
cluded in  Table I.  It  may be  seen  that  protection following endotoxin  ad- 
ministration  was  of similar magnitude  to  that  observed after immunization 
with intact cryptococcus cells. 
In each of the 5 experiments in which modification of infection was demon- 
strated the mice became sick after the injection of endotoxin. Zero to 40 per 
cent of the mice so inoculated died within 96 hours. The survivors demonstrated 
ruffled fur, and ate and drank poorly for a period of 48 to 96 hours. No correla- 
tion  was  noted  between  the  severity of endotoxin sickness  and  subsequent 
protection. Thus, groups of mice which became sick but had no mortality from 
the  endotoxin demonstrated the  same degree of resistance to challenge that 
was noted in groups which became sick and had a 40 per cent mortality. All 
survivors  appeared  well  at  the  time of cryptococcal challenge  1  week  after 
endotoxin administration. 
The mice  were given the  same  lot of endotoxin in  the  sixth  experiment. 
None became ill and no subsequent protection was  observed. The failure of 
the  endotoxin to produce illness or later protection has  not been explained. 
3.  The Specificity  of Immunity Induced  with  Intact Cryptococcal Cells.- 
In three experiments  (Experiments 4  to 6  Table I)  mice were immunized 
with intact cryptococcus cells according to regimens detailed above which had 
been  shown  to  produce  significant  modification  of subsequent  cryptococcal 
challenge. Groups of immunized mice were then challenged with Staphylococcus TABLE I 
The Effect  of Immunization  with  C.  neoformans  and  Bacterial  Endotoxin  on  Survival  Time 
and  Survivorship  Following  Intravenous*  Challenge  with  2.5  X  I06  Cells 
of C. neoformans,  Strains 1148 or 1149 
Exp. 
No.  Immunizing method 
days 
Control  20 
B-27 2X  107 
IP~ X  3 
JN 2 X  107 
IPX  3 
Heat-killed 1148 
2  X  l0  T  IP X  3 
Degree of statistical 
significance of pro- 
longation of life 
0/10 
33  0/9  0.01 
27  0/8  0.05 
19  0/10  Not significant 
Control  37  0/12 
B-27 2 X  107  48  0/10  0.05 
IPX3 
JN 2 X  107  44  0/13  Not significant 
IPX3 
Heat-killed 1148  34  0/12  Not significant 
2 X  107 IP X  3 
Control  52  5/15 
B-27 2  X  107  >104  10/15  0.05 
IPX3 
JN 2  X  l&  > 104  8/15 
IPX3 
Endotoxin 100 #g.  >  104  13/15 
IPX  1 
Control  16  0/9 
36  4/12 
Not significant 
B-27  2  X  10  ~ 
IPX3 
1148 2.5  X  10  s 
IPX  1 
0.01 
0.01 
62  3/9  0.01 
* IV, intravenous. 
:~ IP, intraperitoneal. 
650 TABLE  I--Conduded 
Exp. 
No.  Immunizing method 
1148 2.5X  10  e 
IV X  1 
1149 2.5 X  l0  s 
IPX  1 
Endotoxin 100/~g. 
IPX1 
Control 
B-27 2 X  107 
IPX3 
1149 2.5 X  los 
IPX  1 
Endotoxin 100 #g. 
IPX  1 
Control 
B-27 2 X  107 
IPX3 
1148 2.5 X  106 
IVX  1 
Endotoxin 150 #g. 
IPX  1 
Control 
B-27 2 X  10  g 
IPX3 
Endotoxin 200 #g. 
IPX  I 
Control 
B-27 2 X  107 
IPX3 
Endotoxin 100 #g. 
IPX  1 
50 per cent 
survival 
days 
104 
49 
66 
15 
33 
96 
13 
6 
67 
13 
15 
18 
32 
59 
,3 Inos. 
survival 
Survivors/ 
infected 
7/9 
4/9 
4/9 
0/10 
2/10 
7/12 
0/12 
0/12 
5/11 
2/8 
2/10 
1/13 
6/14 
4/14 
Degree of statistical 
significance of pro- 
longation of hfe 
0.01 
0.01 
0.01 
0.05 
0.01 
Not significant 
0.01 
0.05 
0.05 
0.05 
0.05 
0.05 
0.05 
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aureus,  strain  AZ,  Klebsiella pneumoniae,  strain  Melton,  or  Mycobacterium 
tuberculosis, strain H37Rv. Each of the 3 microorganisms was also inoculated 
into a  group of control mice. Mice immunized with cryptococcus cells were 
not  significantly protected  against  challenge  with  staphylococci,  klebsiellae 
or mycobacteria. Thus,  immunized and  control mice died at  approximately 
the same rate following challenge with each of the three heterologous micro- 
organisms.  Indeed, when small numbers of virulent cryptococci were used in 
the immunization schedule, subsequent challenge with M. tuberculosis resulted 
in  more  rapid  death  than  was  observed  in  control  mice  infected with  M. 
tuberculosis  alone.  Whether  these  deaths  were  due  to  enhancement  of  the 
cryptococcosls or the tuberculosis was not investigated. 
A  typical experiment is shown in  Fig.  3. 
The injection of intact cryptococcus cells appeared then to confer specific 
immunity. There was no evidence that such immunization protected against 
heterologous microbial challenge. 
4.  Tissue Population Studies Following Intravenous Injection of Large Numbers 
of Virulent Cryptococci.-- 
(a)  Liver, lung, kidney,  and brain populations in normal mice: 
Initial  trapping  of fungi was  maximum in  the liver following intravenous 
injection of 2.5 X  10  e cells of strains 1148 or 1149. Total number of cryptococci 
in the liver 4 hours after infection ranged from 1.2 X  105 to 4.2 X  105. Kidney, 
lung, and brain populations were on the average 6- to 100-fold lower at this 
time.  Kidney and lung census ranged from 2.4  X  108 to 2  X  105 per organ. 
Populations were smallest in the brain and varied from 6  X  102 to 1.2  X  10  ~ 
cells per brain. 
Brain and fiver populations did  not change significantly over the first 24 
hours.  During  the  same  period  kidney  and  lung  census  fell an  average  of 
approximately ~  and 2/~ log unit respectively. A significant increase in fungus 
census as compared to that observed 24 hours after infection was noted in each 
of the 4  tissues  studied  7 days after infection. Multiplication  was  slower in 
each  organ between  the  7th  and  14th  day of infection. 
Maximum cryptococcus census was found in the brain at the end of both 
the 7 and 14 day periods. Brain cryptococcus populations varied from 7 X  106 
to  5  X  107  7  days  after infection. Lung  and  kidney census  were  generally 
somewhat lower at the end of the  1 week period ranging from 9.2  X  103 to 
1.4 X  l0  T per organ.  Multiplication was generally least marked in the liver. 
Liver census varied from 1.3  X  106 to 1.1  X  l0  T per organ. 
During the 1st week of infection brain populations usually rose over 5000- 
fold. Lung and kidney census generally increased 50- to 500-fold. Liver popula- 
tions rose only 10- to 50-fold. 
These findings are summarized in Figs. 4 to 7. w  >_ 
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FIG.  4.  Liver cryptococcus populations following  intravenous  infection  with  2.5  X  10  e  cells  of 
strain 1149. 
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(b)  Kidney and brain cryptococcus census in specifically and non-specifically 
immunized mice during the first 7 days of infection. 
Three individual experiments  were performed  in which a  total of 18 to 20 
mice from each  group were studied during the initial 24 hours of infection 
and 14 or 15 were studied 7 days after challenge. Results were similar in all 
3  experiments  and are recorded  together. Strain B-27 was used for specific 
immunization i~ each of the 3 studies. 
Populations in control and immunized mice were generally similar  during 
the first 24 hours of infection. At the end of 7 days, however, striking differences 
were  noted in  tissue  fungus census. 
Brain populations were markedly smaller in 11 of 15 specifically immunized 
mice as compared  to control animals.  The cryptococcal  census in the brains 
of these 11 animals 1 week after infection ranged from 2.7 X  104 to 3  X  105, 
an average increase of 38.3 times the titer found during the first 24 hours after 
challenge. Brain populations in control mice ranged from 7 X  106 to 5 X  107 
7 days after infection, a mean increase of 5,550-fold. Brain fiters for the whole 
group of 15  specifically immunized mice averaged 16-fold lower than values 
for control animals,  a difference which is statistically highly significant  (p  < 
0.01).  On  the  contrary, brain  populations  in  endotoxin-treated mice  were 
only slightly (3.4-fold) smaller  than those observed  in control  animals.  The 
endotoxin-treated:  mice  were, nevertheless,  protected to  the same  degree  as 
specifically immunized mice  whose brain  census  1 week after infection was 
markedly lower  than  control  populations. 
These observations  are depicted in Fig. 8. 
Findings in the kidneys were less striking. Cryptococcus census in specifically 
immunized mice averaged 5-fold less than controls 7 days after infection. This 
difference  between  the  renal  census  in  specifically immunized mice  and  in 
control animals was significant at the 0.05 level. Kidney populations in endo- 
toxin-treated mice were generally  somewhat greater than those observed  for 
specifically immunized  animals but averaged 2.7-fold lower than populations 
noted in control mice.  There was  considerable  overlapping  of values found 
for kidney censns~ in endotoxin-treated mice and those Observed in control or 
specifically  immunized  animals.  The  renal  titers  in  endotoxin-treated mice 
were not statistically different from either controls  or specifically immunized 
mice. 
These observations  are summarized in Fig. 9. 
In summary, protection in specifically immunized mice was associated  with 
a  slower rate of fungus multiplication in the kidneys and brain during the 
first  7  days after challenge.  Non-specific  immunity, induced with bacterial 
endotoxin, was associated with similar protection to that observed with specifi- 
cally immunized mice, but there was only slight inhibition of fungus multiplica- 
tion in the brains and kidneys of these mice during the initial 7 days following 
challenge. 8.0 
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(c)  Tissue  populations observed  in immunized mice  3  to  6  months after 
challenge. 
Tissue cryptococcus  census was determined in the liver-spleen, lung, brain, 
and kidneys of 4 or 5 mice from each of 4 groups surviving at least 3 months 
after challenge. These groups  included 3 immunized specifically according  to 
the different regimens  previously described  and one group  immunized non- 
specifically with bacterial endotoxin. 
Populations were generally markedly smaller  than those observed  in  the 
organs of control mice dying 14 to 28 days after infection. These observations 
are recorded in Table II. 
No significant differences were noted among the 4 groups of immunized mice 
studied. 
Striking  differences,  however,  were  detected  among  the  organs  studied. 
Infection was most markedly diminished in the liver and spleen. In 11 of the 
17 mice no cryptococci could be recovered from the combined liver and spleen. 
Persistent infection on the other hand was uniformly observed  in the brain 
and kidney. Lung populations  were  intermediate. Five of  17  mice  had  no 
fungi cultured from the lungs  at autopsy. 
Thus clearance  of infection was maximum in the liver,  the organ of least 
multiplication in normal mice. Clearance on the other hand was less marked 
in the lungs and was least rapid in the brain and kidneys. 
5.  Tissue  Populations  in  Normal  Mice  Following  Intravenous  Injection 
of Small Numbers  of Virulent  Cryptococci.-- 
Twenty-seven mice were inoculated intravenously with 108 cells of virulent 
strain 1149. Five mice were sacrificed for determination of liver, spleen, lung, 
kidney, and brain cryptococcus  census,  1 day, 1 week,  1 month, 3 months, 
and 6 months after infection. Two mice died during the 6 month experimental 
period,  one 5 weeks after, and the other 5~'~ months after infection.  Tissue 
populations were also determined in these mice. 
The results  of this study are shown in Table III. 
One day after infection,  the cryptococcus  populations  were  largest in  the 
combined liver and spleen, the total number of fungus cells ranging from 2.4 × 
102 to 8.0  ×  10  ~. Lung and kidney census was approximately 10-fold lower. 
Brain populations were smallest, and in 3 of the 5 mice studied, no cryptococci 
were detected. 
During the first 7 days of infection progressive multiplication was observed 
in all tissues  examined.  Fungus census at this time ranged from 6  X  102 to 
1.16 X  106 cells per organ.  Multiplication was generally greatest in the brain 
and least in the liver and spleen. 
During  the  next  6  months  tissue  populations  fell  progressively  in  most 
mice. Three months after infection, 3 of the 5 mice had virtually cleared their DONALD  B.  LOURIA  659 
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tissues  of detectable  cryptococci. Infection in  the other  two mice had  also 
markedly diminished in most tissues, each having a  single organ from which 
relatively large numbers of cryptococci could still be recovered. 
Six months after infection, cryptococci were not detected in the tissue of 
4 of the S mice. Small numbers of cryptococci (4.8  X  101) were found in the 
brain of the fifth mouse but other tissues were sterile. 
Two of the 27 mice died with high tissue fungal census during the 6 month 
experimental period.  In one dying 5  weeks after inoculation the lungs were 
the organ of the maximum infection. The other animal appeared  well for 5 
months,  then became  ill and  died,  51/~ months after infection. At autopsy, 
cryptococcus populations were largest in  the  brain. 
DISCUSSION 
These studies have demonstrated that: 
1.  The course of a  lethal cryptococcus infection in mice could be modified 
by prior injection of small numbers of a  virulent large capsule strain, or by 
injection of either small or large numbers of the same strain when it had de- 
creased in virulence during serial passage on agar.  Similar protection could 
also be produced by immunization with large numbers of a less virulent small 
capsule  strain  of  Cryptococcus neoformans. Thus,  immunization  with  one 
strain of Cryptococcus neoformans protected animals against challenge with a 
different strain.  Immunization with Cryptococcus neoformans var innocuous, 
produced less  modification of lethal cryptococcosis and  injection with heat- 
killed cryptococci effected no protection. The induced immunity was species- 
specific and did not confer protection against heterologous microbial challenge 
with  staphylococci, klebsiellae,  or  tubercle  bacilli. 
2.  Modification of  lethal  cryptococcosis  was  also  produced  by  the  prior 
administration of bacterial  endotoxin. It has  been  shown dearly that  such 
immunity is non-specific and will confer protection against challenge with a 
variety of heterologous microorganisms (19,  20).  The studies on non-specific 
resistance have not previously analyzed the effect of endotoxin administration 
on  subsequent  mycotic  challenge. 
3.  Specific and non-specific immunity produced generally similar prolonga- 
tion of life and approximately the same increase in 3 month survivorship. 
4.  The brain, the organ of maximum multiplication in normal mice during 
the first 14 days following intravenous injection of cryptococci, and the kidney, 
demonstrated  the  greatest  incidence  of  persistent  infection  in  immunized 
mice 3 to 6 months after challenge. The liver, the organ in which cryptococcus 
multiplication was smallest in normal animals, was the site of greatest clearance 
of the fungus 3 to 6 months after challenge. 
5.  The  inoculation  of  small  numbers  of  virulent  cryptococci  into  non- 
imunized mice produced progressive disease in all tissues studied during the DONALD B.  LOUlUA  661 
early  phase  of  the  infection.  Subsequently there  was a  marked  decrease in 
tissue fungus  census  with  eventual apparent  eradication  of the infection  in 
most animals.  In an occasional  animal host defenses were inadequate and the 
mouse died with large tissue cryptococcal populations. 
Although protection was of similar  degree in specifically and non-specifically 
immunized  mice,  the  mechanism  of  protection  appeared  to  be  distinctly 
different. In specifically  immunized mice tissue multiplication  of cryptococci 
was strikingly inhibited during the 1st week of infection.  In mice non-specifically 
immunized with bacterial endotoxin, on the other hand,  tissue multiplication 
was only slightly diminished during the first 7 days of infection. 
The mechanisms of specific and non-specific  immunity were not defined in 
this study. It seems reasonable, nevertheless, to assume that specific immunity 
is associated with the appearance of protective antibody. Agglutinating  and 
precipitating  antibodies have been clearly demonstrated  in rabbits following 
immunization  with  cryptococci  (7-9).  Studies  are  currently  in  progress  to 
determine  whether  agglutinating  and/or  cryptococcus-inhibiting  antibody 
appears  in  the blood of specifically  immunized  mice.  Studies are also being 
performed to determine whether specific immunity is associated with altered 
cellular  response to cryptococcal invasion. 
Two alternative explanations seem possible for the protection of endotoxin- 
treated mice in the absence of inhibition of fungus multiplication  during  the 
1st week of infection.  First it is possible that brain populations 14 days after 
infection,  at the time controls began to die,  would have been similar in endo- 
toxin-treated and control mice and that endotoxin-protected mice did not die 
despite high  cryptococcus titers.  The  administration  of endotoxin  produces 
profound physiological  and  biochemical alterations  in the host  (21,  22).  Re- 
sistance  is  increased  to  later  challenge  with  homologous  and  heterologous 
microorganisms,  and  the  animal  also  becomes more  resistant  to  the  lethal 
effects of microbial toxins (23, 24).  It is possible that death in cryptococcus- 
infected mice is related not only to the conncentration of cryptococci in tissues 
but also to undefined toxic substances. Salvin (25) has suggested that crypto- 
cocci do posses potentially lethal  toxins.  Endotoxin-treated  mice might  then 
be protected by their ability to resist toxic death despite high  fungus census 
until specific host-immune mechanisms become effective. 
This explanation seems less likely in view of the fact that,  in most control 
mice, death appeared to be related to extensive hydrocephalus which occurred 
14 to 28 days after infection.  This was readily apparent upon inspection of the 
animal.  Protection  in  endotoxin-treated  mice  was  clearly  associated  with 
failure  to  develop hydrocephalus.  It  seems  unlikely  that  endotoxin-treated 
mice  would fail  to  develop hydrocephalus  14  to  28  days after  challenge  if 
brain populations were similar  at that time to those observed in control ani- 
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The second alternative, therefore,  appears  more plausible.  It seems  quite 
possible that the endotoxin administration enhanced the immune response of 
the mouse so that antibody response was greater and/or more rapid following 
subsequent cryptococcus  challenge. It has been  shown that the simultaneous 
administration of small amounts of endotoxin and protein antigens markedy 
enhances the subsequent immune response to that antigen (26, 27). No increase 
in antibody response was observed in the aforementioned studies when polysac- 
charides  were used as the antigen.  The cryptococcus-agglutinating  and pre- 
cipitating antibodies  in the rabbit appear to be related to the antigenicity of 
the capsule which is primarily polysaccharide  in nature (5). Whether the pro- 
tective antibody presumed  to be present in immunized mice is also related to 
the capsular antigen is not known. It seems equally possible that such antibody 
is evoked by non-polysaccharide  antigens in the yeast cell or cell wall. 
If the mobilization of protective antibody were accelerated and/or increased 
so that significant antibody was present one week after infection in endotoxin- 
treated but not in control mice, the small decrease in renal and brain fungus 
census observed  in endotoxin-immunized  animals at that time would  be  ex- 
plained. 
It  would  then  be  anticipated  that  tissue  cryptococcus  census  would  be 
significantly smaller  than control  populations at the end of the 2nd  week of 
infection at which time gross hydrocephalus begins to appear in controls  but 
not in endotoxin-immunized  mice. This hypothesis is under investigation at 
present as is a third possibility,  namely that cellular defenses were altered in 
endotoxin-treated animals. 
The  ability of  most  mice  to  contain and  eventually eradicate  infection 
initiated with small numbers of cryptococci  of strain  1149 appears  to be of 
special significance. It seems likely in view of the early generalized progression 
of infection  that host defenses  in  the non-immunized  mouse  are  relatively 
poor.  Adequate defenses are acquired  in most mice after the 1st week. This 
sequence of events suggests that the acquisition  of adequate defenses may be 
closely correlated  with the development of specific antibody. 
It should  be emphasized  that the findings herein reported concerning  the 
acquisition of adequate defenses following infection with small inocula may not 
apply to certain other more virulent strains of Cryptococcus neoformans. Hasen- 
clever and Mitchdl (28) recently studied a strain of Cryptococc~ neoformans 
which produced progressive infection and death following intravenous inocula- 
tion of 103 cells. It seems entirely  possible that growth within the brain was more 
rapid  during the  1st  week  of infection  with this  strain so  that subsequent 
antibody production may have been  ineffective  is  preventing the observed 
hydrocephalus. 
It is of course uncertain as to whether the findings in these experiments  in 
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nervous system is clearly the tissue of maximum infection (1).  Littman (29) 
has suggested that the central nervous system is the site of maximum crypto- 
coccal census in man because  the thiamine content of cerebrospinal fluid is 
optimum for cryptococcal capsular formation. 
The results of these studies suggest the following alternative thesis. 
1.  Infection is initiated with small numbers of cryptococci. In man the site 
of invasion is commonly in the respiratory tract (1). 
2.  Early cellular and  humoral defenses are  poor  so that progressive local 
infection ensues, accompanied frequently by fungemia. 
3.  Increase in fungus census occurs in all tissues involved by fungemic spread. 
Subsequent limitation and eradication of infection is then dependent primarily 
on the production of specific antibody. In patients whose immune mechanisms 
are deranged, progressive infection in many tissues is likely to follow crypto- 
coccal  invasion.  Clinical evidence  offers some  support  for  this  thesis  since 
widespread  visceral  cryptococcosis is  limited almost  exclusively to  patients 
with  severe underlying disease of the reticuloendothelial system  (30)  whose 
immune mechanisms are dearly deficient (31, 32). 
4.  Central nervous system invasion follows fungemia in some patients. Here 
as in other tissues, control of infection is dependent on the development of 
specific  antibody. Although the blood-cerebrospinal fluid barrier is markedly 
deranged  in  cryptococcosis  s,  it  is  unlikely that  the antibody concentration 
would be as large as that in blood. Infection in the central nervous system 
would then be less well controlled, thus establishing this as the site of maximum 
fungus census in the later stages of the disease. 
SUMMARY 
The course of lethal  cryptococcosis  in mice was modified by immunization 
with the same strain or different strains of Cryptococcus neoformans. Protection 
was associated with a definite decrease in tissue fungus multiplication over the 
initial  7  days of infection. Such  immunity was  species-specific  and  did  not 
protect  against heterologous challenge with Staphylococcus aureus, Klebsiella 
pneumoniae, or Mycobacterium tuberculosis. 
Similar modification of lethal cryptococcosis was produced by intraperitoneal 
inoculation of 100 to 200 #g. of Salmonella endotoxin 7 days prior to challenge. 
In  non-specifically (endotoxin)  immunized mice  there  was  only a  minimal 
reduction in tissue cryptococcus census during the 1st week of infection. 
When  small  numbers  of virulent  cryptococci were  injected  intravenously 
into normal mice, tissue populations rose markedly in all organs studies during 
s Unpublished studies by the author have demonstrated that the blood-cerebrospinal fluid 
bromide ratio fails from the normal 2.5 to 3.0:1 to  1:1 in cryptococeal  meningitis in man. 
These findings are similar to those found in tuberculous meningitis (33) and indicate a marked 
alteration in the blood-cerebrospinal fluid barrier. 664  IMMUNITY  IN  CRYPTOCOCCOSIS 
the first 7 days. A progressive fall in tissue fungus census was then observed 
in most mice during the next 6  months. 
The  increase  in  resistance  to  cryptococcal  challenge  following  specific 
immunization, the non-specific protection conferred by injection of bacterial 
endotoxin and  the  ability  to  control and eventually reduce infections with 
small  inocula may well  be  dependent  in  each  case  on  the  development of 
specific antibody. 
The technical assistance of Nancy Fallon is gratefully acknowledged. 
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